ABEONA THERAPEUTICS INC
NASDAQ: ABEO (Abeona Therapeutics Inc.)
Kemas kini terakhir: 2 hari lalu, 9:52PM4.87
0.00 (0.00%)
| Penutupan Terdahulu | 4.87 |
| Buka | 4.88 |
| Jumlah Dagangan | 637,490 |
| Purata Dagangan (3B) | 1,669,396 |
| Modal Pasaran | 263,911,920 |
| Harga / Pendapatan (P/E TTM) | 4.02 |
| Harga / Pendapatan (P/E Ke hadapan) | 476.19 |
| Harga / Jualan (P/S) | 734.22 |
| Harga / Buku (P/B) | 1.51 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| EPS Cair (TTM) | -0.630 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 57.92% |
| Nisbah Semasa (MRQ) | 4.90 |
| Aliran Tunai Operasi (OCF TTM) | -59.88 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -39.71 M |
| Pulangan Atas Aset (ROA TTM) | -49.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -271.78% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Abeona Therapeutics Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 2.13 |
|
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company’s development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 5.84% |
| % Dimiliki oleh Institusi | 63.35% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Western Standard Llc | 30 Sep 2025 | 1,249,957 |
| 683 Capital Management, Llc | 30 Sep 2025 | 770,000 |
| Julat 52 Minggu | ||
| Median | 20.00 (310.68%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 13 Oct 2025 | 20.00 (310.68%) | Beli | 5.41 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |